The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Exploring genetic ancestry and tumor mutation profiles in renal clear cell carcinoma: A comprehensive analysis using The Cancer Genetic Ancestry Atlas.
 
Michelle J Lee
No Relationships to Disclose
 
Shalini Vemuru
No Relationships to Disclose
 
Christopher H Rhee
No Relationships to Disclose
 
Marcus Moses
No Relationships to Disclose
 
Deven Patel
No Relationships to Disclose
 
Bassel Nazha
Honoraria - Intellisphere, LLC (Onclive)
Consulting or Advisory Role - Cardinal Health; Exelixis; IntrinsiQ
 
Mehmet Asim Bilen
Consulting or Advisory Role - AstraZeneca; Bayer; Bristol-Myers Squibb; Calithera Biosciences; Eisai; EMD Serono; Exelixis; Exelixis; Genomic Health; Janssen; Nektar; Pfizer; Sanofi; SeaGen
Research Funding - Advanced Accelerator Applications (Inst); AstraZeneca (Inst); Bayer (Inst); Bristol-Myers Squibb (Inst); Exelixis (Inst); Genentech/Roche (Inst); Genome & Company (Inst); Incyte (Inst); Merck (Inst); Nektar (Inst); NiKang Therapeutics (Inst); Peloton Therapeutics (Inst); Pfizer (Inst); Seagen (Inst); Tricon Pharmaceuticals (Inst); Xencor (Inst)
 
Jacqueline T Brown
Consulting or Advisory Role - Exelixis; Xencor
Research Funding - Hookipa Pharma (Inst); Medicenna (Inst); Merck (Inst); Surface Oncology (Inst); Xencor (Inst)